|home | contact us | join our cause|
|About Us||Research & News||Public Policy||Grassroots Initiatives|
What is CRSCM?
CRSCM is a national coalition of patient advocacy nonprofits, consumer healthcare organizations, businesses, researchers, and professional associations dedicated to educating the general public and policymakers on the therapeutic potential of the stem cells found in umbilical cord blood and tissue. Cord blood stem cells have already been used in more than 25,000 transplants worldwide for certain cancers, immune disorders and blood and immune diseases. More recently, the use of one’s own cord blood stem cells is helping to advance the field of regenerative medicine in clinical trials for conditions like cerebral palsy, traumatic brain injury and hearing loss.
What is Regenerative Medicine?
Regenerative medicine is a promising new field of medicine that focuses on many novel treatment approaches including using an individual’s own stem cells to treat failing, impaired or injured tissues. Current research is exploring the use of a child’s own cord blood stem cells as potential treatment for cerebral palsy and other neurological disorders, traumatic brain injury, hearing loss and type 1 diabetes.
How Are Newborn Stem Cells Being Used in Medical Treatments Today?
Stem cells from umbilical cord blood have been used in more than 25,000 transplants worldwide during the last 20 years to treat a wide range of life-threatening diseases in both adults and children. Cord blood stem cells are safe, effective, approved for therapeutic use and have unique characteristics compared with other sources of stem cells. Today, clinical studies involving the use of one's own cord blood stem cells are exploring new treatment options for diabetes, traumatic brain injury, cerebral palsy, hearing loss and other conditions.
Who Should Join CRSCM and Why?
Any entity, regardless of size, sector, or geographic location that supports the CRSCM mission should join the coalition. Regenerative therapies are the future of medicine and the use of one's own cord blood provides a source of unique stem cells and a safe approach for researching new therapies. Joining CRSCM will give you and your organization the ability to play a leading and active role in advancing stem cell science and your voice will help CRSCM advocate for measures that increase access to cord blood banking and create greater awareness of the use of cord blood in regenerative medicine.
How Much Does it Cost To Join CRSCM and to What Am I Committing By Joining?
There are no fees or shared costs for membership in CRSCM.
By joining CRSCM, you are allowing the coalition to list your organization's name on its roster of members as a supporter of the coalition's mission. Any other use of your organization's name would require your prior approval. For members who are so inclined, there will be opportunities (joint letters, meetings, special events, etc.) for coalition members to actively promote the impact that greater utilization of cord blood banking will have on healthcare and disease before Congress, the media, and the American public.
Where Does CRSCM Stand on Federal Legislation?
CRSCM believes that federal legislation is needed to educate expectant women about cord blood banking and to allow families to use tax-free dollars to make cord blood banking more affordable. The coalition has currently endorsed two federal bills including the “Family Cord Blood Banking Act” (H.R. 1614), which will allow families to use tax-free health dollars for qualified cord blood banking services, and the "Cord Blood Education and Awareness Act ", which will institute national education on cord blood banking options and standardize informed consent on cord blood stem cells for pregnant women.
The coalition will not take positions on local ordinances or state legislation.
Where does CRSCM stand on Embryonic Stem Cells?
CRSCM remains neutral on the issue of embryonic stem cells. The coalition is singularly focused on the use of cord blood stem cells in regenerative medicine and will take no position on embryonic stem cells.
|Copyright © 2013 CRSCM. All rights reserved.|